Prescription opioid use among older adults with arthritis or low back pain

Arthritis Care and Research

Volumn 55, Issue 1, 2006, Pages 35-41

  Solomon, Daniel H ^a,b   Avorn, Jerry ^a   Wang, Philip S ^a   Vaillant, George ^a   Cabral, Danielle ^a   Mogun, Helen ^a   Stürmer, Til ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Division of Pharmacoepidemiology   (United States)

Author keywords

Health services use; Low back pain; Opioid analgesics; Osteoarthritis; Prescription patterns; Rheumatoid arthritis

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; TRAMADOL;

AGED; ARTHRITIS; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS; PATIENT SELECTION; PREDICTION; PRESCRIPTION; PROPORTIONAL HAZARDS MODEL;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; LOW BACK PAIN; MALE; MEDICARE; MYOCARDIAL ISCHEMIA; OSTEOARTHRITIS; PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 32544437033     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21697     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Healthy people 2010. Washington, DC: US Government Printing Office; 2000.
2. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
3. American Pain Society. Promoting pain relief and preventing abuse of pain medications: a critical balancing act a joint statement from 21 health organizations and the Drug Enforcement Administration. URL: http://www. ampainsoc.org/ advocacy/promoting.htm.
4. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15.
5. Arthritis Pain Guideline Panel of the American Pain Society. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. Glenview (IL): American Pain Society; 2002.
6. Hermos JA, Young MM, Gagnon DR, Fiore LD. Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patients. Arch Intern Med 2004;164:2361-6.
7. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004;109:514-9.
8. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003;12:315-26.
9. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998;41:1603-12.
10. Gonzales GR, Portenoy RK. Selection of analgesic therapies in rheumatoid arthritis: the role of opioid medications. Arthritis Care Res 1993;6:223-8.
11. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind? Pain 2004;109:207-9.
12. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999;83:761-86.
13. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's pharmacological basis of therapeutics. New York: McGraw-Hill; 1996.
14. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.